boolean
Dr. John Lekkas

Reviewed By: Dr. John Lekkas

GMC Registration: 7448560

Last reviewed on: 15/06/2026

Shipping Across the UK

Icon Cold-Chain Transportation

Icon UK Mainland Weekday delivery

Icon Channel Islands (Two-day delivery service)

Icon Northern Ireland (one to two-day delivery service)

Icon Shipped Monday - Friday

In-stock

Wegovy Pill

  • Daily tablet for weight management support
  • No injections, just one tablet daily
  • Up to 16.6% average weight loss
  • MHRA-approved for weight management
  • Prescribed to recognised UK standards
  • Sign Up for Updates

Wegovy tablets contain semaglutide, the same active ingredient used in Wegovy injections, and are taken once daily. They are the first GLP-1 weight-loss medication available as a tablet, offering a practical needle-free option for weight management support.


    No spam. We only email you when tablets reach the UK.

    What is the Wegovy pill?

    The Wegovy pill is a prescription-only oral semaglutide treatment being developed to support weight management in adults living with obesity or weight-related health conditions. Taken once daily, it is designed to help reduce appetite, manage hunger levels, and support healthier eating habits alongside lifestyle changes

    Wegovy weight loss tablets contain the same active ingredient used in semaglutide injections and work by helping to regulate appetite. While not yet available in the UK, they may offer a convenient needle-free option for eligible adults in the future.

    Eligibility criteria for the Wegovy pill

    The Wegovy pill may be suitable for adults with a BMI of 30 or above, or a BMI of 27 or above when weight-related health conditions are present. However, the treatment is not appropriate for everyone. Before starting, a healthcare professional will assess your medical history, current health, and any medicines you are taking to determine whether treatment is suitable.

    Before taking Wegovy weight loss pills, tell your clinician if you:

    • Are over 85 years of age
    • Have type 2 diabetes
    • Have a history of pancreatitis
    • Have severe heart failure
    • Have gastroparesis, which slows stomach emptying
    • Have diabetic eye disease or experience changes in vision
    • Are scheduled for surgery requiring general anaesthetic or deep sedation
    • Are pregnant, breastfeeding, or planning a pregnancy
    • Have severe kidney disease
    • Have severe liver disease

    Do not take this medication if you are allergic to semaglutide. Inform your clinician about all medicines you use, including levothyroxine, warfarin, and herbal supplements, as these may affect treatment. Effective contraception is recommended during treatment, and extra precautions may be needed if vomiting or diarrhoea occurs.

    What is Wegovy weight loss pen?
    Fill Out Free Consultation

    Fill out the Online Form

    Fill out our online consultation form with valid and accurate patient information and medical conditions.

    Select Treatment

    Select Treatment

    Select the weight loss treatment you are prescribed. We will suggest the options based on your eligibility.

    Track & Receive

    Track & Receive

    Your treatment will be dispensed and delivered to your doorstep by a tracked courier service.

    How does the Wegovy pill help you lose weight?

    The Wegovy pill contains semaglutide, a GLP-1 mimicking ingredient that acts on natural hormones involved in appetite control. It supports weight loss by helping to reduce hunger, control cravings, and promote a feeling of fullness for longer after eating.

    It also slows how quickly food leaves the stomach and helps regulate blood sugar levels, which can further support appetite control and reduce spikes that trigger cravings.

    Is the Wegovy pill safe?

    Yes. Wegovy pills have been approved by the MHRA, confirming they meet strict UK standards for safety, quality, and effectiveness in weight management.

    Wegovy pill doses

    The Wegovy pills have been studied in four daily dose strengths as part of weight-management research:

    • 1.5mg
    • 4mg
    • 9mg
    • 9mg
    • 25mg

    Like other semaglutide treatments, dosing is usually increased step by step, beginning with a lower strength before moving to higher doses. This gradual approach helps support treatment effectiveness, while the tablet strengths are specifically designed for oral absorption.

    How effective is Wegovy for weight loss?
    Effective Wegovy

    How effective are Wegovy tablets?

    Clinical trials have highlighted the potential effectiveness of Wegovy weight loss tablets for long-term weight management. Participants taking a daily 25mg tablet achieved an average weight loss of 16.6% after 64 weeks, compared with 2.7% in the placebo group.

    In addition, many participants were able to achieve meaningful weight-loss goals, with a greater proportion losing 5% or more of their initial body weight during the study period.

    Expected weight changes across Wegovy dose levels

    Wegovy Weight loss outcomes depend on dose progression, consistency, and lifestyle habits. Higher doses typically provide stronger appetite regulation, although individual responses differ and require clinical review.

    Days on Treatment Wegovy Pills Dose
    1 to 30 1.5 mg
    31 to 60 4 mg
    61 to 90 9 mg
    91+ 25 mg

    Side effects of the Wegovy tablets

    As with any prescription treatment, some people may experience side effects while taking the Wegovy pill. These are usually mild and tend to improve over time as the body becomes accustomed to the medication. Side effects are most commonly reported during the first few weeks of treatment or after increasing the dose.

    Very common side effects (affecting more than 1 in 10 people) include:

    • Headache
    • Nausea
    • Vomiting
    • Diarrhoea
    • Constipation
    • Stomach pain
    • Tiredness or weakness
    • Indigestion

    Common side effects (affecting up to 1 in 10 people) include:

    • Dizziness
    • Bloating, wind, and burping
    • Gastritis
    • Heartburn or acid reflux
    • Changes in taste
    • Gallstones
    • Hair loss
    • Tingling or burning sensations
    • Low blood sugar in people with type 2 diabetes

    Uncommon side effects (affecting up to 1 in 100 people) include:

    • Low blood pressure
    • Feeling faint when standing up
    • Fast heartbeat
    • Delayed stomach emptying
    • Raised pancreatic enzyme levels
    • Low blood sugar in people without type 2 diabetes
    • Increased bilirubin levels, which may cause yellowing of the skin or eyes

    Rare side effects (affecting up to 1 in 1,000 people) include:

    • Allergic reactions
    • Sudden swelling
    • Hip fracture

    Always read the patient information leaflet before starting treatment. If you experience persistent or concerning symptoms, seek advice from your clinician.

    How to use Wegovy pens?

    Table of Contents

    Wegovy pill vs injectable Wegovy: What is the difference?

    Feature Wegovy Pill Wegovy Injection
    How it is used Taken as one tablet a day. Taken as one injection a week.
    Active ingredient Semaglutide. Semaglutide.
    Treatment option No injections needed. Weekly dosing for added convenience.
    Hunger support Helps control appetite. Helps control appetite.
    Weight-loss benefits Supports healthy weight loss alongside diet and exercise. Supports healthy weight loss alongside diet and exercise.
    Available in the UK Not currently available. Available for eligible adults with a prescription.

    Finding the right weight-loss approach for you

    Each treatment offers a different way to support long-term weight management while working through similar appetite-control mechanisms. Your choice should be guided by your personal preferences, medical needs, and advice from a qualified clinician.

    How much will the Wegovy pill cost in the UK?

    The price of the Wegovy pill in the UK has not been officially confirmed yet. Once it becomes available, the cost is expected to vary depending on the clinic or healthcare provider supplying the treatment.

    Are there other weight-loss medications?

    Yes, a range of weight-loss tablets are available in the UK, although they work differently from GLP-1 treatments. The Wegovy pill is expected to be the first GLP-1 tablet designed specifically for weight management, while oral semaglutide medicines such as Rybelsus are currently prescribed for type 2 diabetes.

    Other tablets may help support weight loss by reducing appetite, limiting fat absorption, or influencing hunger-related signals in the brain.

    When will Wegovy tablets be available?

    Wegovy pills have been approved by the MHRA and are expected to be available in the UK soon. They are intended for adults living with obesity (BMI 30+) or those who are overweight (BMI 27–30) with related health conditions.

    What our customers say

    We pride ourselves on great customer service. Here are some comments left by our customers.

    Michelle

    Very easy and quick consultation process. Weight loss pens arrived the next day.

    Mary

    Friendly customer service team, responded promptly and professionally to my questions.

    Amy

    Ordered on Tuesday and it arrived on Wednesday morning. Very well packed. Excellent service.

    FAQs

    How should I store a Wegovy Pen?
    Keep Wegovy refrigerated before first use, stored between 2°C and 8°C, and avoid placing it near the freezer compartment. After opening the pen, you may continue storing it in the fridge or keep it at room temperature below 30°C. If the pen remains unused for 6 weeks, discard it safely. Always replace the pen cap after use to protect the medication from light.
    After opening, Wegovy can remain outside the fridge for up to 6 weeks as long as temperatures stay below 30°C. Store the pen in its original packaging and keep it in a cool, dry area away from direct sunlight.
    You can request Wegovy through a regulated private online service. A UK-licensed prescriber will review your medical details to confirm suitability. If approved, our registered pharmacy dispenses the medication and delivers it directly to your address in discreet packaging.
    • Complete the confidential online consultation form
    • Provide details about your health history and weight goals
    • A licensed prescriber reviews your assessment
    • If appropriate, Wegovy or an alternative may be recommended
    • Once approved, your prescription is issued
    • Your medication is delivered discreetly to your home
    Wegovy is approved for long-term weight management in the UK. Progress is monitored during treatment, with a key review point at six months to confirm meaningful weight reduction. If at least 5% of the starting weight is lost and benefits continue, treatment may carry on under prescriber supervision.
    Start by completing an online consultation. Licensed clinicians assess your BMI, medical background, and weight-related health factors. If you meet the prescribing criteria, we will issue an online Wegovy prescription.
    Yes, switching treatments is possible. After reviewing your medical history, a prescriber will advise when to stop Mounjaro and how to begin Wegovy safely. In most cases, the transition happens within a short timeframe to maintain treatment continuity.
    Yes, you may take your dose one day earlier if at least three days have passed since your last injection. Always confirm schedule changes with our prescriber to ensure ongoing safety and clinical benefit.
    No generic version of Wegovy is currently available in the UK. Patent protection remains in place, with a potential generic expected after 2031. At present, Wegovy is prescribed only as a branded medication.
    Hunger can occur if you are early in treatment, have not reached your maintenance dose, or are not meeting nutritional needs. Following a balanced eating plan is essential. If appetite remains high, our prescriber may review your dose or discuss alternative treatment options.
    When prescribed appropriately, Wegovy is considered safe for many people. However, it may not suit individuals with certain medical conditions. A full medical assessment ensures suitability of Wegovy in the UK, and any ongoing or new symptoms should be discussed with our prescriber.
    It is not recommended to drink alcohol while using Wegovy. It adds extra calories, may interfere with progress, and can increase side effects such as dizziness or nausea. Alcohol and Wegovy can also lower blood sugar, so moderation is strongly advised.
    No, Wegovy does not directly burn fat. Instead, it reduces appetite and increases fullness, helping you maintain a calorie deficit. Fat loss occurs through dietary control and physical activity alongside treatment.
    Return used pens and needles to a pharmacy offering medication disposal services. Never place needles in household waste. Using a sharps bin is recommended, and disposal supplies can be added during assessment.
    Administer Wegovy once weekly using the pre-filled pen. Inject into the abdomen, thigh, or upper arm with the fine needle provided. After injection, dispose of the needle safely in a sharps bin.
    Each Wegovy pen supplies four weekly doses, covering approximately one month of treatment. Doses increase gradually to support tolerability.
    Wegovy can be used long-term; clinical studies support use for up to two years. If you achieve at least 5% weight loss within six months and continue benefiting, treatment may continue under medical guidance.
    If side effects such as nausea, vomiting, or diarrhoea continue or become difficult to manage, contact our prescriber for guidance. They may suggest practical ways to ease symptoms or adjust your dose if needed. Our prescriber will confirm when it is appropriate to move to the next dose level. If symptoms cause concern or worsen, refer to the patient information leaflet or seek medical advice promptly.
    Yes, the MHRA has licensed Wegovy for weight management in the UK. It is prescribed following a medical assessment.
    Carry Wegovy in your hand luggage when travelling. Use a cooling case to keep it between 2°C and 8°C. Bring your Wegovy prescription and follow airline medication regulations.
    Wegovy medication may support heart health by reducing blood pressure, improving cholesterol levels, and lowering triglycerides. Weight reduction can also decrease strain on the cardiovascular system.
    Do not use Wegovy during pregnancy. If planning pregnancy, stop treatment at least two months beforehand. This reduces potential risk to pregnancy development. Refer to the patient leafletfor full safety details.
    Some adults may notice slower weight loss progress after the early stages of treatment as the body adapts over time. Factors such as eating habits, physical activity levels, sleep, stress, and dose progression can all influence long-term results. A clinical review may help determine whether treatment adjustments or lifestyle changes are needed.
    Wegovy may still support appetite control and weight reduction without structured exercise, but long-term outcomes are often improved when treatment is combined with regular physical activity and balanced eating habits. Exercise may also help support energy levels, muscle health, and sustainable weight management.
    Some adults may be able to restart Wegovy after a treatment break if they still meet prescribing requirements following clinical assessment. Depending on how long treatment has been paused, restarting may involve returning to a lower dose to help reduce the risk of side effects.
    If you are of childbearing age, discuss contraception with our prescriber before starting Wegovy. Options may include oral or non-oral methods, depending on individual needs and suitability.
    Wegovy does not reduce pill effectiveness. However, severe vomiting or diarrhoea may affect absorption. In such cases, additional contraceptive measures or medical advice may be required.
    Clinical studies over 68 weeks showed average weight loss of up to 15–17% when Wegovy was used with diet and exercise. Ongoing support helps individuals work toward realistic weight goals.
    Wegovy is usually prescribed for adults with a BMI of 30 or above, or 27 and above with weight-related conditions such as high blood pressure, diabetes, or high cholesterol. Eligibility is confirmed through medical review.
    Wegovy is supplied in pre-filled pens ranging from 0.25mg to 2.4mg. Treatment begins at the lowest dose and increases gradually to improve tolerability.

    The most common side effects include:

    • Mild nausea
    • Bloating
    • Constipation
    • Fatigue (especially in the early weeks of treatment)

    These effects often improve as treatment continues. Support is available for managing symptoms.

    Other prescription options include Mounjaro, Saxenda, and Nevolat. These treatments work similarly and may be considered if Wegovy is not suitable.  Our clinicians may also discuss Non-prescription strategies.
    No. Wegovy is only available with a prescription in the UK following assessment by a licensed clinician.
    Achieving a healthier weight can reduce the risk of heart disease, stroke, type 2 diabetes, and certain cancers. Clinical studies also show improvements in blood pressure, cholesterol, and inflammation markers.
    No. Both contain semaglutide, but Wegovy is licensed for weight loss, while Rybelsus is prescribed for type 2 diabetes. They differ in purpose, dosing, and formulation.
    Do not use Wegovy while breastfeeding. It is unclear whether the medication passes into breast milk, so treatment should be avoided during this period. For a complete description of any Wegovy side effects and restrictions, please make sure to read the Patient Information Leaflet.
    The Wegovy injection cost on the prescribed dose. Full Wegovy price information is provided during consultation so you can make an informed decision.
    Yes. Mental health support is available for those who need help managing emotional or behavioural challenges related to weight loss.
    Plateaus can occur as the body adapts to changes. Adjustments to treatment, diet, or activity levels may help restart progress.
    Wegovy and Ozempic both contain semaglutide, but they are prescribed for different purposes. It is approved for weight loss, while Ozempic is used to manage type 2 diabetes. Although they share the same active ingredient, their dosing differs to suit these distinct uses. Wegovy medication primarily supports appetite control, whereas Ozempic focuses on blood sugar regulation in people with diabetes. The maximum Ozempic dose is 2mg, used only when lower doses do not adequately control blood glucose.
    There are no over-the-counter versions of Wegovy available in the UK. While some non-prescription products claim to support weight loss, none offer the same mechanism of action or clinical evidence as Wegovy. Prescription assessment is required to ensure suitability and safety.
    Using other weight loss medications alongside Wegovy is not recommended. The safety of combining these treatments has not been established, and doing so may increase the risk of side effects. In particular, you should not take any other medicines containing GLP-1 receptor agonists while using Wegovy, even if they are prescribed for diabetes.

    If you are currently using Saxenda or have used it previously, the following guidance applies:

    • If you are taking Saxenda 3.0mg once daily: You may switch to Wegovy 0.5mg once weekly. Although both medicines belong to the GLP-1 class, they contain different active ingredients. Starting at 0.5mg helps reduce the risk of side effects. After four weeks, the dose may be increased gradually in line with prescribing guidance.
    • If you are taking a lower dose than 3.0mg of Saxenda: You should start Wegovy at 0.25mg.
    • If you previously used Saxenda but had a long break in treatment: Restarting at 0.25mg Wegovy is advised to improve tolerability.

    Fatigue (especially in the early weeks of treatment) These effects often improve as treatment continues. Support is available for managing symptoms.

    If you are currently using Ozempic or have used it previously for weight loss, the following guidance applies:

    • If you are currently taking Ozempic: You may switch to the equivalent dose of Wegovy or the next dose level. For example, if you are on 1.0mg Ozempic, you may move to 1.7mg Wegovy.
    • If you have had a short treatment gap of a few weeks: You may continue Wegovy at the dose you previously reached.
    • If you were previously taking Ozempic 1.0mg and had a longer break: Restarting Wegovy at 0.5mg is recommended to reduce the risk of side effects such as nausea.
    • If Ozempic is prescribed for type 2 diabetes: You should continue using Ozempic and not switch to Wegovy. Wegovy is not licensed for diabetes management.
    Semaglutide is the active ingredient contained in Wegovy. It is a branded form of semaglutide that is specifically licensed for weight management. Other medicines, such as Ozempic and Rybelsus, also contain semaglutide but are licensed for the treatment of type 2 diabetes rather than weight loss.

    If you are switching from Ozempic used for weight loss, the same guidance applies:

    • If you are currently on Ozempic: You may switch to the same or next higher dose of Wegovy.
    • If you had a short break in treatment: You may continue from your previous dose level.
    • If you had a longer treatment gap: Restarting at 0.5mg Wegovy is safer and helps reduce side effects.

    If Ozempic is being used for type 2 diabetes, you should not switch to Wegovy. Switching from Saxenda to Wegovy (summary guidance)

    • Saxenda 3.0mg daily → Wegovy 0.5mg weekly
    • Lower Saxenda dose → Wegovy 0.25mg
    • Long gap after Saxenda → Wegovy 0.25mg

    Dose increases should follow manufacturer guidance and clinical advice.

    Wegovy is exclusively offered as an injectable treatment. While oral GLP-1 medications are available, they are not currently part of our service offerings. However, a new oral GLP-1 treatment is being developed, with manufacturers aiming for approval by 2026.
    • Ongoing review and support from UK-licensed clinicians
    • Online consultations designed to fit around your schedule
    • Guidance on nutrition alongside medication use
    • Discreet delivery to your home
    • Clear pricing with no unexpected costs
    • Needles provided at no charge, with sharps bins available if required

    Here's how you can easily order Wegovy from Mayfair:

    • Complete the confidential online consultation form
    • Provide details about your health history and weight goals
    • Guidance on nutrition alongside medication use
    • A licensed prescriber reviews your assessment
    • If appropriate, Wegovy or an alternative may be recommended
    • Once approved, your prescription is issued
    • Your medication is delivered discreetly to your home

    Large meals, greasy foods, highly processed snacks, and excessive sugar may worsen nausea or digestive discomfort during treatment. Many people tolerate smaller balanced meals more comfortably while using Wegovy injections.

    Most Wegovy side effects are temporary and often improve as the body gradually adjusts to treatment. Symptoms such as nausea, bloating, stomach discomfort, or headache commonly become milder over time, but persistent or severe symptoms should always be reviewed by a healthcare professional.

    Dr. John Lekkas

    Reviewed By: Dr. John Lekkas

    GMC Registration: 7448560

    Dr John Lekkas is a GMC registered medical doctor with a specialist PhD, and is a global leading expert in weight loss and aesthetic medicine.

    Last reviewed on: 15/06/2026

    Start free Consultation

    Speak with our clinical team and get personalised advice.

    Start Consultation

    Can We Help?

    Contact Us Now

    Lowest Price Promise: If you find this treatment cheaper elsewhere, we will refund you the difference.

    Start Consultation